Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study
- PMID: 36166113
- DOI: 10.1007/s11060-022-04134-0
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study
Abstract
Purpose: Surgery is the treatment of choice for large vestibular schwannomas (VS). Stereotactic radiosurgery (SRS) has been suggested as an alternative to resection in selected patients. However, the safety and efficacy of SRS in Koos grade IV patients ≤ 45 years old has not been evaluated. The aim of this study is to describe the clinical and radiological outcomes of Koos grade IV in young patient managed with a single-session SRS.
Methods: This retrospective, multicenter analysis included SRS-treated patients, ≤ 45 years old presenting with non-life threatening or incapacitating symptoms due to a Koos Grade IV VS and with follow-up ≥ 12 months. Tumor control and neurological outcomes were evaluated.
Results: 176 patients [median age of 36.0 (IQR 9) and median tumor volume of 9.3 cm3 (IQR 4.7)] were included. The median prescription dose was 12 Gy (IQR 0.5). Median follow-up period was 37.5 (IQR 53.5) months. The 5- and 10-year progression-free survival was 90.9% and 86.7%. Early tumor enlargement occurred in 10.9% of cases and was associated with tumor progression at the last follow-up. The probability of serviceable hearing preservation at 5- and 10-years was 56.8% and 45.2%, respectively. The probability of improvement or preservation of facial nerve function was 95.7% at 5 and 10-years. Adverse radiation effects were noted in 19.9%. New-onset hydrocephalus occurred in 4.0%.
Conclusion: Single-session SRS is a safe and effective alternative to surgical resection in selected patients ≤ 45 years old particularly those with medical co-morbidities and those who decline resection. Longer term follow up is warranted.
Keywords: Koos grade IV; Stereotactic radiosurgery; Vestibular schwannoma; Young age.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Kshettry VR, Hsieh JK, Ostrom QT et al (2015) Incidence of vestibular schwannomas in the United States. J Neurooncol 124:223–228. https://doi.org/10.1007/s11060-015-1827-9 - DOI - PubMed
-
- Koos WT (1988) Criteria for preservation of vestibulocochlear nerve function during microsurgical removal of acoustic neurinomas. Acta Neurochir (Wien) 92:55–66. https://doi.org/10.1007/BF01401974 - DOI
-
- Goldbrunner R, Weller M, Regis J et al (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-Oncology 22:31–45. https://doi.org/10.1093/neuonc/noz153 - DOI - PubMed
-
- Ogino A, Lunsford LD, Long H et al (2021) Stereotactic radiosurgery as the primary management for patients with Koos grade IV vestibular schwannomas. J Neurosurg. https://doi.org/10.3171/2020.8.JNS201832 - DOI - PubMed
-
- Iorio-Morin C, AlSubaie F, Mathieu D (2016) Safety and efficacy of Gamma Knife radiosurgery for the management of Koos grade 4 vestibular schwannomas. Neurosurgery 78:521–530. https://doi.org/10.1227/NEU.0000000000001154 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
